TK
Housey Pharmaceutical Research Laboratories Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Axulin | Not specified | Commercial |
| Diabetes Therapeutic | Diabetes | Not specified |
| Theramutein Program | Drug-resistant cancers | Pre-clinical/Discovery |
Leadership Team at Housey Pharmaceutical Research Laboratories
GM
Gerard M. Housey, M.D., Ph.D.
President/CEO
EB
Ed Bastyr, III, M.D.
Chief Medical Officer
TR
Timothy R. Franson, M.D.
Head of Global Regulatory Affairs